REFERENCES
- Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000;342:1255–1265.
- Mesa R, Barosi G, Cervantes F. Myelofibrosis with myeloid metaplasia: Disease overview and non-transplant treatment options. Best Practice & Research Clinical Hematology. 2006;19:495–517.
- Caijo Y, Almange C, Boutin J, Leblay R, Guerin D. Renal lesions in myelofibrosis. Sem Hop. 979;55:1271–1274.
- Ferhanoglu B, Erzin Y, Başlar Z, Tuzuner HA. Secondary amyloidosis in the course of idiopathic myelofibrosis. Leukemia Research. 1997;21:897–898.
- Oesterling JE, Keating JP, Leroy AJ, Idiopathic myelofibrosis with myeloid metaplasia involving the renal pelvis, ureters and bladder. J Urol. 1992;147:1360.
- Liu TT, Chen JB, Chen WJ, Kuo CY, Lee CT. Idiopathic myelofibrosis associated with renal extramedullary hematopoiesis and nephrotic syndrome: Case report. Chang Gung Med J. 2000;23:169–174.
- Pamuk ON, Pamuk GE, Altiparmak MR, Sonsuz A, Solakoglu S, Kilicaslan I. Nephrotic syndrome associated with agnogenic myeloid metaplasia. Leuk Lymphoma. 2002;43: 661–663.
- Chan KW, Ho CP. Amyloidosis complicating idiopathic myelofibrosis. Am J Kidney Dis. 1999;34:E27.
- Kwak H, Lee J. CT findings of extramedullary hematopoiesis in the thorax, liver and kidneys in a patient with idiopathic myelofibrosis. J Korean Med Sci. 2000;15:460–462.
- Cameron JS. Focal segmental glomerulosclerosis in adults. Nephrol Dial Transplant. 2003;18(Suppl. 6):45–51.
- Perazella MA, Buller GK. Nephrotic syndrome associated with agnogenic myeloid metaplasia. Am J Nephrol. 1994;14: 223–225.
- Gordon BR, Coleman M, Kohen P. Immunologic abnormalities in myelofibrosis with activation of the complement system. Blood. 1981;58:904–910.
- Vellenga E, Mulder N. A study of the cellular and humoral immune response in patients with myelofibrosis. Clin Lab Heamatol. 1982;4:307–316.
- Centenara E, Guarnone R, Ippoliti G, Barosi G. Cyclosporine-A in severe refractory anemia of myelofibrosis with myeloid metaplasia: A preliminary report. Hematologica. 1998;83: 622–626.
- Savin VJ, Sharma R, Sharma M, Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med. 1996;334:878–883.
- Schnuelle P, Waldherr R, Lehmann KJ, Idiopathic myelofibrosis with Extramedullary hematopoiesis in the kidneys. Clin Nephrology. 1999;52:256–262.
- Abboud HE. Role of platelet-derived growth factor in renal injury. Annu Rev Physiol. 1995;57:297–309.
- Sterzel RB, Hartner A. Schlotzer-Schrehardt U, et al. Elastic fiber proteins in the glomerular mesangium in vivo and in cell culture. Kidney Int. 2000;58:588–602.
- Daniel V, Trautmann Y, Konrad M, Nayir A, Schärer K. T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clin Nephrol. 1997;47:289–297.
- Cattran DC, Appel GB, Hebert LA, A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int. 1999;56:2220–2226.
- Pietrasanta D, Clavio M, Vallebella E, Beltrami G, Cavaliere M, Gobbi M. Long-lasting effect of cyclosporine-A on anemia associated with idiopathic myelofibrosis. Hematologica. 1997;82:458–459